Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy

The goal of this pilot clinical trial is to learn about efficacy of acupuncture about blood pressure fluctuation during total laparoscopic hysterectomy in patients with uterine fibroid.Participants will receive two times of acupuncture treatment before surgery and researchers will compare to see if acupuncture treatment would stabilize blood pressure fluctuation especially from induction time to post-incision moment.

Adulthood participants who were planned to have surgical removal of uterus for uterine fibroid and have expected date of total laparoscopic hysterectomy by a gynecologist were eligible.Inclusion criteriabetween age of 19 and 69,American Society of Anesthesiologists (ASA) class I or II,required surgical removal of uterus by a gynecology specialist,scheduled to have total laparoscopic hysterectomy in advance.Exclusion criteriaexpected survival within 3 months,emergency operation which was not scheduled in advance,hypertension or hypotension that can significantly interfere with the study result,diagnosis of arrhythmia, such as atrial fibrillation, frequent ventricular or supraventricular premature beats,diagnosis of heart failure or valvular disease,anemia of hemoglobin < 12 g/dL,incapable of surgery due to hemodynamic or medical reasons other than stated above,incapable of receiving acupuncture treatment on determined location,current use of gonadotropin-releasing hormone receptor agonists,current use of drugs that may interfere with the result, including steroids, immunosuppressants, and psychiatric disorders,significant comorbidities that may interfere with the interpretation of intervention efficacy or results, such as stroke, myocardial infarction, kidney disease, dementia, or epilepsy,pregnant, planning to be pregnant within study period, or breastfeeding,previous participation in any other clinical trial within 1 month of participation, planning to participate another clinical trial within 6 months after enrollment date, or planning to participate another clinical trial on follow-up period,fail to write the informed consent form voluntarily,being deemed to be unsuitable for participation.